Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/31/2010CN101683320A Olprinone hydrochloric parenteral solution and method for preparing same
03/31/2010CN101683319A Tirapazamine parenteral hydrous preparation and preparation method thereof
03/31/2010CN101683316A Temperature responsive bio-adhesive in situ gel sustained-release preparation for vagina
03/31/2010CN101683315A Preparation method of composite hyaluronic acid-sulfadiazine silver gel
03/31/2010CN101683311A Uses of dithiolane compounds for the photoprotection of the skin, dithiolane compounds and compositions containing same
03/31/2010CN101683310A Anthranilic acid amides and the derivatives thereof as cosmetic and pharmaceutical agents
03/31/2010CN101683074A Pharmaceutical composition for disinfecting livestock and poultry environments and aquatic water bodies and preparation method thereof
03/31/2010CN100596332C Medicine-carrying contact lens and preparation method thereof
03/31/2010CN100596299C Dehydrosilibinin diester derivatives, preparation method and use thereof
03/31/2010CN100596298C 4-deoxyisopodophyllotoxin derivatives, preparation and medicinal uses thereof
03/31/2010CN100596294C 4'-substituted benzyloxy-phenyl butadiene derivatives and preparation and uses thereof
03/31/2010CN100596282C Liuweidihuang multiple vatimines and its preparing method
03/31/2010CN100596281C Plant extracting liquid capable of relieving eye disease
03/31/2010CN100596280C Film for treating oral ulcer and preparation method thereof
03/31/2010CN100596279C 'Fu Kang Shu' cream for treating gynecological inflammation and preparation method thereof
03/31/2010CN100596278C Medicinal composition for preventing and treating senile osteoarthropathy
03/31/2010CN100596277C Medicinal composition for promoting enterogastric peristalsis
03/31/2010CN100596276C Slow-released vincamine capsule and its preparation process
03/30/2010US7687665 2-(4-Chlorophenyl)-N-[(1R,2R)-2-(benzyloxy)cyclohexyl]-2-methylpropanamide; modulators of 11- beta hydroxyl steroid dehydrogenase type 1 and/or mineralocorticoid receptor
03/30/2010US7687662 e.g. 1-({[(2,3-difluorobenzoyl)amino]acetyl}amino)-3-methylbutyl]boronic acid; anticarcinogenic, antiproliferative agent
03/30/2010US7687651 Method for the preparation of trans-or cis-diammoniumdichlorodihydroxoplatinum(IV) and the use thereof in the production of pharmaceutical active substances
03/30/2010US7687644 Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
03/30/2010US7687643 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
03/30/2010US7687640 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde; inhibits production of A beta 40 and A beta 42 from amyloid precursor protein ; Alzheimer's disease and Down syndrome
03/30/2010US7687639 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide
03/30/2010US7687638 C-(3-Methyl-5-phenyl-3H-benzoimidazol-4-yl)-methylamine; diabetes, fasting plasma glucose (IFG), metabolic acidosis, ketosis, appetite regulation, obesity, immunosuppressants or cytokine release regulation, autoimmune diseases such as inflammatory bowel disease, multiple sclerosis and arthritis
03/30/2010US7687637 5-phenylthiazole derivatives and use as Pi3 kinase inhibitors
03/30/2010US7687636 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
03/30/2010US7687634 Insecticidal N-substituted (6-haloalkylpyridin-3-yl)alkyl sulfoximines
03/30/2010US7687628 Method of preparing 4-amino-1H-imidazo(4,5-c)quinolines and acid addition salts thereof
03/30/2010US7687627 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
03/30/2010US7687625 Antidiabetic agents; obesity; controlling appetite
03/30/2010US7687623 2,2,2-Trichloro-1-{10-[(2'-methoxy-1,1'-biphenyl-4-yl)carbonyl]-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl}ethanone; reacting a tricyclic diazepine with diphosgene and a primary or secondary amine
03/30/2010US7687620 [1,4]diazepino[6,7,1-IJ]quinoline derivatives as antipsychotic and antiobesity agents
03/30/2010US7687619 Room temperature stable agarose solutions
03/30/2010US7687617 Oligonucleotides with alternating segments of locked and non-locked nucleotides
03/30/2010US7687547 Diphenyl ether antimicrobial compounds
03/30/2010US7687546 Quaternary ammonium compound, process for producing the same, therapeutic agent for cerebrovascular disorder, and therapeutic agent for heart disease
03/30/2010US7687545 Thiocolchicine dimers with thiocolchicine residues are liked through a linear aliphatic amido or amido-ureido bridge; antiproliferative, antiinflammatory, antiarthritic, antiviral; enhanced cytotoxicity; 3,5-benzenedicarboxylic acid bis-(N-deacetylthiocolchicine) amide
03/30/2010US7687544 Method of using catalpic acid to treat type 2 diabetes and associated disorders
03/30/2010US7687543 Use of polyunsaturated ketones for the treatment of psoriasis
03/30/2010US7687542 Rapidly bioavailable tablet and capsule formulations of diclofenac
03/30/2010US7687541 4-[4-Acetoxy-2-(3,4-difluoro-phenyl)-3-(4-methanesulfonyl-phenyl)-but-2-enoyloxy]-2-(3,4-difluoro-phenyl)-3-(4-methanesulfonyl-phenyl)-but-2-enoic acid, sodium salt; water solubility; administering by biological injection; antiinglammatory agents(NSAIDS); side effect reduction
03/30/2010US7687540 Substituted propane phosphinic acid esters
03/30/2010US7687539 Method of treating ocular allergy
03/30/2010US7687538 Agents with selective κ-opioid receptor affinity
03/30/2010US7687537 N-[(4,5-diphenyl-2-thienyl)methyl]amine derivatives, their preparation and their therapeutic application
03/30/2010US7687536 Aminocycloalkyl cinnamide compounds for arrhythmia and as analgesics and anesthetics
03/30/2010US7687535 Substituted 3-sulfur indoles
03/30/2010US7687534 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
03/30/2010US7687532 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritis
03/30/2010US7687530 Inhibition of chronic tissue transplant rejection
03/30/2010US7687529 treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders; 1'-[3-(methylamino)-1-phenylpropyl]spiro[cyclohexane-1,3'-indol]-2'(1'H)-one
03/30/2010US7687528 combination comprising as active ingredients an AT1-receptor antagonist or a pharmaceutically acceptable salt thereof, an insulin secretion enhancer or a pharmaceutically acceptable salt thereof, or an insulin sensitizer or a pharmaceutically salt thereof and a carrier; valsartan; diabetes treatment
03/30/2010US7687527 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
03/30/2010US7687526 Benzo-fused compounds for use in treating metabolic disorders
03/30/2010US7687525 e.g. N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; anticarcinogenic, antitumor agents; hematologic malignancy and a solid carcinoma; autoimmune disease, skin disorders;
03/30/2010US7687524 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders
03/30/2010US7687523 3-heteroaryl-3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists
03/30/2010US7687522 N-(4-(6-(1-methyl-6-oxo-2-(phenylamino)-1,6-dihydropyrimidin-5-yl)pyridin-3-yloxy)pyridin-2-yl)pyrrolidine-1-carboxamide; anticarcinogenics, antiproliferatives, angiogenesis inhibitors; hepatocyte growth factor mediated diseases
03/30/2010US7687521 biphenyl-2-ylcarbamic acid 1-[2-(4-{[(R)-2-(3-formylamino-4-hydroxyphenyl)-2-hydroxyethylamino]methyl}-2,5-dimethylphenylcarbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity; pulmonary disorders
03/30/2010US7687520 Serotonin and norepinephrine reuptake inhibitors and uses thereof
03/30/2010US7687519 Biphenyl compounds useful as muscarinic receptor antagonists
03/30/2010US7687518 4-Tetrazolyl-4-phenylpiperidine compounds for prophylaxis and therapy of pain or diarrhea in an animal
03/30/2010US7687517 3,9-Diazabicyclo [3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/30/2010US7687516 Alcohol free formulation of argatroban
03/30/2010US7687515 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
03/30/2010US7687514 Benzimidazole derivatives
03/30/2010US7687513 liquidus range of the ionic pyridinium-based compounds is between about -73 degrees C. (-99 degrees F.) to about 447 degrees C. (837 degrees F.); heat transfer fluids, solvents, catalysts, lubricants
03/30/2010US7687512 Use of pyridinyl-pyrimidinylamino-benzamide derivatives for the treatment of amyloid related disorders
03/30/2010US7687511 Substituted dihydropyrimidines, dihydropyrimidones and dihydropyrimidinethiones as calcium channel blockers
03/30/2010US7687510 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
03/30/2010US7687509 N-(2-(4-(4-fluoro(benzyl-d6)carbamoyl)-5-hydroxy-1-(methyl-d3)-6-oxo-1,6-dihydropyrimidin-2-yl)-(1,3-d6-propan)-2-yl)-5-(methyl-d3)-1,3,4-oxadiazole-2-carboxamide; use in methods of treating HIV infections
03/30/2010US7687508 Cyclic derivatives as modulators of chemokine receptor activity
03/30/2010US7687507 Protein tyrosine kinase, such as Janus Kinase 3, inhibitors, immunosuppressants; organ transplants, lupus, multiple sclerosis, psoriasis; antidiabetic agents, antiarthritic agents, anticarcinogenic agents, Alzheimer's Disease, Crohn's Disease, Inflammatory Bowel Disease, autoimmune thyroid disorders
03/30/2010US7687506 Selective serine/threonine kinase inhibitors
03/30/2010US7687505 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
03/30/2010US7687504 1-[3-[2-[2-cyano-(S)-pyrrolidin-1-yl]-2-oxo-ethylamino]-1-oxo-propyl]-4-[bis-(4-fluorophenyl)methyl]piperazine; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes
03/30/2010US7687503 2-(methylamino)-2-oxoethyl 4-{5-[3-(trifluoromethyl)-phenyl]-2-pyridyl}-1-piperazinecarboxylate, for example; enzyme inhibitors of fatty acid amide hydrolases; treatment of pain, eating disorders, neurological and psychiatric pathologies, among other disorders
03/30/2010US7687502 Substituted quinazoline or pyridopyrimidine derivative
03/30/2010US7687501 fused tricyclic compounds useful as metabotropic glutamate receptor (mGluR) antagonists, particularly as selective metabotropic glutamate receptor 1 antagonists
03/30/2010US7687500 Substituted oxetanes, method of making, and method of use thereof
03/30/2010US7687499 (4-cyclopropyl-piperazin-1-yl)-(4-morpholin-4-ylmethyl-phenyl)-methanone, and (4-cyclopropyl-piperazin-1-yl)-[4-(2-hydroxymethyl-morpholin-4-ylmethyl)-phenyl]-methanone, for example; treatment of a variety of CNS related disorders including narcolepsy, sleep disorders, obesity
03/30/2010US7687498 N-(Arylidene)morpholinylpyridinylhydrazine derivatives, e.g., N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-2-yl}-N'-(3-methyl-benzylidene)-hydrazine, are used for treating interleukin-12 overproduction-related disorders including inflammatory diseases
03/30/2010US7687497 C10-substituted camptothecin analogs
03/30/2010US7687496 11-(4S)-[2-(dimethylvinylsilanyl)-ethyl]-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione, for example; anti-tumor agents; potent inhibitors of Topoisomerase I
03/30/2010US7687495 {(2S,4R,5R)-4-(4-Methoxy-phenyl)-5-[4-(3-methoxy-propyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-ylmethoxy]-piperidin-2-yl}-methanol; renin enzyme inhibitor; hypertensive agent; heart/kidney failure; glaucoma cardiac infarction; restenosis; stroke; reduces forming of angiotensin I, therefore angiotensin II als
03/30/2010US7687494 Substituted spirobenzazepines
03/30/2010US7687493 Product, method and intermediates for the preparation of azetidine derivatives
03/30/2010US7687492 1,2,4-Oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
03/30/2010US7687491 Immunosuppressants with low toxicity; 1-({4-Methyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl}methyl)azetidine-3-carboxylic acid for example; autoimmune diseases and transplant rejection; N-substituted azetidine, pyrrolidine or piperidine compounds
03/30/2010US7687490 2-thioethenyl substituted carbapenem derivatives
03/30/2010US7687489 Agent for treatment of cerebral ischemic diseases
03/30/2010US7687488 Such as 1-{[(2S,3S,5R)-2-Carboxy-3-methyl-4,4,7-trioxo-4-thia-1-azabicyclo[3.2.0]hept-3-yl]methyl}-3-methyl-1H-1,2,3-triazol-3-ium; beta-lactamase inhibitors
03/30/2010US7687487 Prodrug, hydrate, solvate, polymorph, tautomer; conjugate with Fluropyrimidine; Pyrimidine Nucleoside; Purine Nucleoside; Antifolate, Platinum Analog; Anthracycline, Anthracenedione; tablet, suspension, solution, gelatin capsule; injection, infusion pump, suppository, retention enema; cancers
03/30/2010US7687486 Selective estrogen receptor modulators
03/30/2010US7687485 Formulation for menopausal women
03/30/2010US7687484 Transporter enhanced corticosteroid activity
03/30/2010US7687483 Phosphorus compounds used for improving permeability of drugs such as anticarcinogenic agents to biological barriers; drug delivery
03/30/2010US7687482 Bisphosphonate compounds and methods
1 ... 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 ... 7860